Stock Code
603707.SH
ABOUT
>
Company profile
Enterprise Culture
Early Warning System
BUSINESS
>
Commercialized Products
MEDIA
>
News in NKF
CONTACT
CH / EN
Home
>
MEDIA
>
News in NKF
>
Paclitaxel For Injection (Albumin Bound) approved by US FDA
2025-05-20
Paclitaxel For Injection (Albumin Bound) approved by US FDA
share
Return
Previous
King-Friend will meet you in CPHI Frankfurt!
Next
NKF's subsidiary Kindos's Mitoxantrone Injection gets FDA approval for marketing
Relevant recommendations
2025-08-04
NKF's subsidiary Kindos's Etoposide Injection gets FDA approval for marketing
2025-07-21
NKF makes its debut at CPHI Southeast Asia
2025-07-14
King-Friend will meet you in CPHI Malaysia！
2025-05-26
NKF's subsidiary Kindos's Idarubicin Hydrochloride Injection gets FDA approval for marketing
2025-05-22
NKF's subsidiary Kindos's Mitoxantrone Injection gets FDA approval for marketing
